FS Development Corp. Contracts & Agreements
74 Contracts & Agreements
- Business Finance (21 contracts)
- Business Operations (16)
- Human Resources (16)
- Intellectual Property (5)
- Mergers & Acquisitions (2)
- Real Estate (2)
- Uncategorized (12)
- Controlled Equity OfferingSM Sales Agreement dated November 15, 2024 by and between Disc Medicine, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 15, 2024)
- Second Amendment to Lease by and between Disc Medicine, Inc. and ARE-MA Region No. 75. LLC, dated August 29, 2024 (Filed With SEC on November 12, 2024)
- Underwriting Agreement, dated as of June 14, 2024, by and among the Company and Leerink Partners LLC, as representative of the several underwriters listed on Schedule I thereto (Filed With SEC on June 14, 2024)
- Transition and Separation Agreement, dated as of November 27, 2023, by and between Disc Medicine, Inc. and Joanne Bryce (Filed With SEC on March 21, 2024)
- Employment Agreement, dated February 7, 2024, by and between Disc Medicine, Inc. and Jean M. Franchi (Filed With SEC on February 7, 2024)
- Amendment No. 1 to Open Market Sale AgreementSM dated December 5, 2023 by and between Disc Medicine, Inc. and Jefferies LLC (Filed With SEC on December 5, 2023)
- Open Market Sale AgreementSM dated October 10, 2023 by and between Disc Medicine, Inc. and Jefferies LLC (Filed With SEC on October 10, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 16, 2023)
- Underwriting Agreement, dated as of June 13, 2023, by and among the Company and Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, and BMO... (Filed With SEC on June 16, 2023)
- Securities Purchase Agreement, dated as of February 13, 2023, by and between Disc Medicine, Inc. and the investors identified therein (Filed With SEC on February 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on February 14, 2023)
- Sales Agreement dated January 25, 2023 by and between Disc Medicine, Inc. and SVB Securities LLC (Filed With SEC on January 25, 2023)
- Common Stock Issuance Agreement, dated as of December 29, 2022, by and between Disc Medicine Opco, Inc., F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc (Filed With SEC on December 29, 2022)
- Form of Registration Rights Agreement (Filed With SEC on December 29, 2022)
- Form of Contingent Value Rights Agreement (Filed With SEC on December 29, 2022)
- Form of Indemnification Agreement for Directors of Disc Medicine, Inc (Filed With SEC on December 29, 2022)
- Form of Indemnification Agreement for Officers of Disc Medicine, Inc (Filed With SEC on December 29, 2022)
- Employment Agreement, dated as of December 29, 2022, by and between Disc Medicine, Inc. and John Quisel, J.D. Ph.D (Filed With SEC on December 29, 2022)
- Employment Agreement, dated as of December 29, 2022, by and between Disc Medicine, Inc. and Joanne Bryce (Filed With SEC on December 29, 2022)
- Employment Agreement, dated as of December 29, 2022, by and between Disc Medicine, Inc. and William Savage, MD, Ph.D (Filed With SEC on December 29, 2022)
- 2017 Stock Option and Grant Plan of Disc Medicine, Inc., and form of award agreements thereunder (Filed With SEC on December 29, 2022)
- Notice of Termination, Separation Agreement and Release, dated as of December 29, 2022, by and between Gemini Therapeutics, Inc. and Brian Piekos (Filed With SEC on December 29, 2022)
- Amendment to Addendum to License Agreement by and among Disc Medicine, Inc., F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated February 28, 2022 (Filed With SEC on September 2, 2022)
- Amended and Restated Investors Rights Agreement, among Disc Medicine, Inc. and certain of its stockholders, dated August 23, 2021 (Filed With SEC on September 2, 2022)
- 2017 Stock Option and Grant Plan of Disc Medicine, Inc., and form of award agreements thereunder (Filed With SEC on September 2, 2022)
- License Agreement by and among Disc Medicine, Inc., F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated May 7, 2021 (Filed With SEC on September 2, 2022)
- License Agreement by and between Disc Medicine, Inc. and AbbVie Deutschland GmbH & Co, KG, dated September 13, 2019 (Filed With SEC on September 2, 2022)
- Lease by and between Disc Medicine, Inc. and ARE-MA Region No. 75, LLC, dated October 29, 2021 (Filed With SEC on September 2, 2022)
- Addendum to License Agreement by and among Disc Medicine, Inc., F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated December 7, 2021 (Filed With SEC on September 2, 2022)
- Second Amendment to Addendum to License Agreement by and among Disc Medicine, Inc., F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated May 31, 2022 (Filed With SEC on September 2, 2022)
- Second Amendment Agreement, dated March 7, 2022, by and between Sanquin Blood Supply Foundation and Gemini Therapeutics Sub, Inc (Filed With SEC on September 2, 2022)
- Agreement and Plan of Merger and Reorganization, dated as of August 9, 2022, by and among Gemini Therapeutics, Inc., Gemstone Merger Sub, Inc. and Disc Medicine, Inc (Filed With SEC on August 10, 2022)
- Form of Disc Support Agreement (Filed With SEC on August 10, 2022)
- Form of Gemini Support Agreement (Filed With SEC on August 10, 2022)
- Form of Lock-Up Agreement (Filed With SEC on August 10, 2022)
- Form of Contingent Value Rights Agreement (Filed With SEC on August 10, 2022)
- Advisory Agreement, dated as of April 15, 2022, by and between Gemini Therapeutics, Inc. and Dr. Samuel Barone (Filed With SEC on May 6, 2022)
- Second Amendment Agreement, dated March 7, 2022, by and between Sanquin Blood Supply Foundation and Gemini Therapeutics Sub, Inc (Filed With SEC on March 10, 2022)
- Description of Securities (Filed With SEC on March 10, 2022)
- Separation Agreement and Release, by and between Gemini Therapeutics, Inc. and Jason Meyenburg, dated February 28, 2022 (Filed With SEC on February 28, 2022)
- Executive Chairman Agreement, dated as of November 15, 2021, by and between Gemini Therapeutics, Inc. and Dr. Georges Gemayel (Filed With SEC on November 15, 2021)
- Retention Agreement, dated as of October 4, 2021, by and between Gemini Therapeutics, Inc. and Dr. Samuel Barone (Filed With SEC on November 15, 2021)
- Employment Agreement, dated as of April 12, 2021, by and between Gemini Therapeutics, Inc. and Dr. Samuel Barone (Filed With SEC on August 12, 2021)
- Employment Agreement, dated as of February 4, 2021, by and between Gemini Therapeutics, Inc. and Brian Piekos (Filed With SEC on May 13, 2021)
- Employment Agreement, dated as of February 22, 2021, by and between Gemini Therapeutics, Inc. and Dr. Walter Strapps (Filed With SEC on May 13, 2021)
- Voting Agreement, dated February 5, 2021, by and among Gemini Therapeutics, Inc. and the other parties thereto (Filed With SEC on February 11, 2021)
- Merger Agreement, dated as of October 15, 2020, by and among Gemini Therapeutics, Inc., Shareholder Representative Services LLC, FS Development Corp., and FSG Merger Sub Inc.... (Filed With SEC on February 11, 2021)
- Form of Specimen Common Stock Certificate (Filed With SEC on February 11, 2021)
- Lockup Agreement, dated February 5, 2021, by and among Gemini Therapeutics, Inc. and the other parties thereto (Filed With SEC on February 11, 2021)
- Gemini 2021 Stock Option and Incentive Plan (incorporated by reference to Annex D to the Proxy Statement/Prospectus) (Filed With SEC on February 11, 2021)
- Forms of Award Agreements under the Gemini 2021 Stock Option and Incentive Plan (Filed With SEC on February 11, 2021)
- Form of Indemnification Agreement for Executive Officers of Gemini Therapeutics, Inc (Filed With SEC on February 11, 2021)
- Form of Subscription Agreement (incorporated by reference to Annex E to the Proxy Statement/Prospectus) (Filed With SEC on February 11, 2021)
- Employment Agreement, dated January 21, 2021, by and between Gemini Therapeutics, Inc. and Jason Meyenburg (Filed With SEC on February 11, 2021)
- Employment Agreement, dated December 24, 2020, by and between Gemini Therapeutics, Inc. and Dr. Marc Uknis (Filed With SEC on February 11, 2021)
- Employment Agreement, dated January 22, 2021, by and between Gemini Therapeutics, Inc. and Dr. Scott Lauder (Filed With SEC on February 11, 2021)
- Form of Indemnification Agreement for Directors of Gemini Therapeutics, Inc (Filed With SEC on February 11, 2021)
- Form of Non-Redemption Agreement (Filed With SEC on November 2, 2020)
- Registration Rights Agreement, dated August 11, 2020, by and among the Company, FS Development Holdings, LLC and the other holders party thereto (Filed With SEC on August 14, 2020)
- Underwriting Agreement, dated August 11, 2020, by and between the Company and Jefferies LLC (Filed With SEC on August 14, 2020)
- Investment Management Trust Agreement, dated August 11, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on August 14, 2020)
- Private Placement Class A Common Stock Purchase Agreement, dated August 11, 2020 by and among the Company and FS Development Holdings, LLC (Filed With SEC on August 14, 2020)
- Letter Agreement, dated August 11, 2020, by and among the Company, its officers, its directors and FS Development Holdings, LLC (Filed With SEC on August 14, 2020)
- Administrative Services Agreement, dated August 11, 2020, by and between the Company and FS Development Holdings, LLC (Filed With SEC on August 14, 2020)
- Form of Underwriting Agreement (Filed With SEC on August 7, 2020)
- Form of Administrative Services Agreement between the Registrant and FS Development Holdings, LLC (Filed With SEC on August 7, 2020)
- Securities Subscription Agreement between the Registrant and FS Development Holdings, LLC (Filed With SEC on August 7, 2020)
- Promissory Note issued to FS Development Holdings, LLC (Filed With SEC on August 7, 2020)
- Form of Indemnity Agreement (Filed With SEC on August 7, 2020)
- Form of Private Placement Class A Common Stock Purchase Agreement between the Registrant and FS Development Holdings, LLC (Filed With SEC on August 7, 2020)
- Form of Registration Rights Agreement among the Registrant, FS Development Holdings, LLC and the Holders signatory thereto (Filed With SEC on August 7, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on August 7, 2020)
- Form of Letter Agreement among the Registrant, FS Development Holdings, LLC and each of the executive officers and directors of the Registrant (Filed With SEC on August 7, 2020)
- Specimen Class A Common Stock Certificate (Filed With SEC on August 7, 2020)
